Pittermann, E., N. Lachmann, G. MacLean, S. Emmrich, M. Ackermann, G. Gohring, B. Schlegelberger, K. Welte, A. Schambach, D. Heckl, S. H. Orkin, T. Cantz and J. H. Klusmann: Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells. In: Blood Adv 1, 14, 903-914 (2017).
url: https://www.ncbi.nlm.nih.gov/pubmed/29296734
Lachmann, N., J. Jagielska, D. Heckl, S. Brennig, N. Pfaff, T. Maetzig, U. Modlich, T. Cantz, B. Gentner, A. Schambach and T. Moritz: MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. In: Gene Ther 19, 9, 915-924 (2012).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21975463
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.